0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Pointers to Cancer Prognosis (Paperback, Softcover reprint of the original 1st ed. 1987) Loot Price: R1,515
Discovery Miles 15 150
Pointers to Cancer Prognosis (Paperback, Softcover reprint of the original 1st ed. 1987): B.A. Stoll

Pointers to Cancer Prognosis (Paperback, Softcover reprint of the original 1st ed. 1987)

B.A. Stoll

Series: Developments in Oncology, 48

 (sign in to rate)
Loot Price R1,515 Discovery Miles 15 150 | Repayment Terms: R142 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The last 30 years have seen little improvement in the age-adjusted mortality rates for most common types of cancer, and until we develop more effective and less damaging treatment modalities for these tumours, selection of each patient's treatment must depend on prognostic pointers. These lead to a calculated trade off between our estimate of likely benefit to the patient, as against cost in terms of quality of life. But changes have occurred recently in our understanding of the traditional prognostic pointers used for selecting such individualised treatment. First, it is increasingly recognised that the stage at which a tumour presents is more related to the chromo logical age of the tumour (how far it has progressed before diagnosis) than to its biological characteristics. While advanced chronological age of the tumour may predict a greater likelihood of early death, only biological criteria can predict the tumour growth rate, the likelihood of prolonged survival, the likely course of the disease after the first recurrence or the likehood of response to systemic therapy. Second, there is increasing use of failure analysis in relating the clinical and biological characteristics of tumours to their response to standard treatments. In the past, the relationship was interpreted mainly in terms of survival rate, but the site and timing of first recurrence and the pattern and timing of subsequent spread provide a better assessment of the control possible from local or systemic therapy."

General

Imprint: Kluwer Academic Publishers
Country of origin: United States
Series: Developments in Oncology, 48
Release date: February 1987
First published: 1987
Editors: B.A. Stoll
Dimensions: 235 x 155 x 20mm (L x W x T)
Format: Paperback
Pages: 368
Edition: Softcover reprint of the original 1st ed. 1987
ISBN-13: 978-0-89838-876-3
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 0-89838-876-7
Barcode: 9780898388763

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners